Summer Sale
50% off Premium Yearly
NASDAQ:INCY
incyte (INCY)
Financials 
Technical Analysis 
Jun 11, 2026, 12:00 amThis summary was created by AI, based on 2 opinions in the last 12 months.
Incyte (INCY-Q) is currently generating mixed reviews from experts. On one hand, it has a projected earnings growth of 19% in 2026 and trades at under 12 times its price-to-earnings (P/E) ratio for that year, indicating it may be undervalued given its robust drug pipeline. On the other hand, there is concern regarding the recent momentum which has significantly declined, paired with a high P/E ratio compared to its peers. Despite an upgrade, some analysts remain cautious, not seeing a clear upward trend in the near future. Overall, while the growth potential is promising, the current market sentiment appears to exhibit hesitation due to valuation concerns and performance issues over the past few months.
The momentum has broken badly and has a high PE. But he entered this on a rebound that has momentum. Despite an upgrade today, he doesn't see a green light ahead.
Joe Terranova- «
- ‹
- 1
- ›
- »
incyte (INCY) Frequently Asked Questions
What is incyte stock symbol?
incyte is a American stock, trading under the symbol INCY (previously INCY-Q on Stockchase) on the NASDAQ (INCY). It is usually referred to as NASDAQ:INCY or INCY
Is incyte a buy or a sell?
In the last year, 2 stock analysts issued a Buy, Sell, or Hold rating on INCY (previously INCY-Q on Stockchase). 1 analyst recommended to BUY and 1 analyst recommended to SELL the stock. The latest stock analyst rating is DON'T BUY. Read the latest stock experts' ratings for incyte.
Is incyte a good investment or a top pick?
incyte was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for incyte.
Why is incyte stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for incyte.
Is incyte worth watching?
incyte is covered by Stockchase experts and is worth watching.
What is incyte stock price?
On 2026-06-12, incyte (INCY) stock closed at a price of $108.53.
Projected 19% earnings growth in 2026, yet trades at under 12x PE 2026. Has a robust drug pipeline.